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The successful use of man-made proteins to advance synthetic biology requires both the fabrication of functional artificial proteins in a 
living environment, and the ability of these proteins to interact productively with other proteins and substrates in that environment.  
Proteins made by the maquette method integrate sophisticated oxidoreductase function into evolutionarily naive, non-computationally 10 
designed protein constructs with sequences that are entirely unrelated to any natural protein. Nevertheless, we show here that we can 
efficiently interface with the natural cellular machinery that covalently incorporates heme into natural cytochromes c to produce in vivo 
an artificial c-type cytochrome maquette.  Furthermore, this c-type cytochrome maquette is designed with a displaceable histidine heme 
ligand that opens to allow functional oxygen binding, the primary event in more sophisticated functions ranging from oxygen storage and 
transport to catalytic hydroxylation.  To exploit the range of functions that comes from the freedom to bind a variety of redox cofactors 15 
within a single maquette framework, this c-type cytochrome maquette is designed with a second, non-heme C, tetrapyrrole binding site, 
enabling the construction of an elementary electron transport chain, and when the heme C iron is replaced with zinc to create a Zn 
porphyrin, a light-activatable artificial redox protein. The work we describe here represents a major advance in de novo protein design, 
offering a robust platform for new c-type heme based oxidoreductase designs and an equally important proof-of-principle that cofactor-
equipped man-made proteins can be expressed in living cells, paving the way for constructing functionally useful man-made proteins in 20 
vivo. 
Introduction 
Man-made proteins have an important role to play in the synthetic 
biology goal of constructing functional parts and devices for 
incorporation into either explicitly biological or artificial 25 
organisms or systems.1 The program to integrate sophisticated 
oxidoreductase function into evolutionarily naive, non-
computationally designed protein constructs is called the 
maquette approach.2,3 By beginning with a generic protein 
sequence designed only to adopt a simple helical bundle fold and 30 
iteratively adding engineering elements onto this stripped-down 
protein chassis, the maquette approach allows the designer to 
avoid the layers of complexity that hinder the redesign of natural 
protein scaffolds. Man-made protein maquettes self-assemble in 
vitro with a wide range of the redox cofactors seen in nature, 35 
including hemes, chlorins, metal ions, flavins and quinones.2  
However synthetic biology requires that functional artificial 
proteins and enzymes interact productively with natural proteins 
and substrates. They must also fully and functionally assemble in 
vivo, meaning that cofactor binding sites must be occupied by the 40 
target cofactors to carry out the desired function. 
Here we test the ability of a novel man-made protein to interface 
with natural proteins in vivo in order to assemble a functional 
redox protein. Despite the completely unnatural protein sequence, 
the natural post-translational machinery of E. coli (Fig. 1A)4 45 
successfully inserts heme B and forms two covalent links 
between the heme vinyls and protein cysteines to create a 
synthetic heme C cytochrome with exceptional efficiency. This 
man-made cytochrome c successfully forms a heme oxy-ferrous 
state with a stability akin to natural oxygen transport proteins 50 
containing heme B,5 but with entirely unrelated sequence or 
structure. As part of a program to design increasingly 
sophisticated man-made oxidoreductases, this protein is equipped 
with an intraprotein electron-transfer chain by including a second 
non-heme C binding site that self-assembles in vitro with heme 55 
B.  Light activated function is added to this dyad by replacing the 
Fe of the original heme C with Zn to create a Zn-porphyrin 
photo-center.  
Results 
Protein and vector design 60 
We have previously designed a functional, man-made maquette 
containing heme B that is capable of reversibly binding molecular 
oxygen (Sequence 1 in Fig. 1B).6 This maquette not only matches 
the diatomic ligand exchange kinetics and spectroscopy of natural 
heme containing globins, but also preferentially binds O2 over 65 
CO. For a more versatile protein capable of taking advantage of 
the functionally diverse option of placing a range of different 
cofactors at two distinct sites, we broke the original dimeric 
symmetry and united the helices with a long, simple connecting 
loop composed of just glycine and serine residues. A short, 70 
stabilizing N-cap sequence was added to the N-terminus of the 
protein to increase thermal stability by restricting protein motion 
(sequence referred herein as 1.5).7 
We wished to include a site amenable to covalent heme C 
attachment for the dual purpose of establishing the interaction of 75 
this man-made protein with evolved natural redox proteins in 
vivo, and secondly to gain a securely attached cofactor that could 
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be exploited under harsh in vitro conditions. The majority of 
natural c-type cytochrome sequences contain a consensus 
CX1X2CH motif necessary for in vivo heme incorporation.4 We 
surveyed the non-redundant PDB for structures with c-type 
hemes attached to helices (150 structures, Supplementary 5 
information, Table S1) and noted the prevalence of small (A/G) 
residues at X2 and a general preference for hydrophobic residues 
at X1 (Supplementary information, Fig. S1). We selected CIACH 
as the c-type incorporation motif (Sequence 2 in Fig. 1B) to 
reflect a balance between maintaining the helicity and structure of 10 
the protein, and satisfying the very broad substrate specificity of 
the promiscuous E. coli c-type heme maturation system (Ccm).4 
Furthermore, this selection is consistent with a previous analysis 
of helical porphyrin-binding sites in heme-containing proteins, 
where the idealized sequence for the most commonly observed 15 
histidine rotamer in helical c-type heme sites was identified as 
CX1ACH.8 To eliminate interference with the added N-cap 
sequence on helix 1, helix 2 was chosen as the site for the 
consensus motif, with the distal ligand provided by the histidine 
on helix 4. The histidines on helices 1 and 3 form an auxiliary 20 
binding site for tetrapyrroles such as heme B (Fig. 1B).  
In addition to the consensus motif, c-type cytochromes must be 
exported to the periplasm for covalent heme incorporation by the 
Ccm machinery.4 We cloned the sequence into the periplasmic 
expression vector pMal-p4x (NEB, USA), replacing the maltose 25 
binding protein (MBP) N-terminal fusion partner with a tobacco 
etch virus protease (TEV) cleavable hexahistidine tag, leaving the 
N-terminal signal peptide attached via the cleavable purification 
tag in the vector pSHTctmaq (Fig. 1C). The signal peptide 
facilitates periplasmic export through the Sec translocon9,10 and is 30 
designed for in vivo cleavage prior to c-type heme incorporation. 
In vivo cofactor incorporation 
To ensure efficient heme incorporation when expressing c-type 
cytochromes, the E. coli Ccm machinery must be co-
expressed.4,10 This can be achieved at low efficiency through 35 
anaerobic growth under nitrate, though the highest levels of heme 
C incorporation in 2 were observed after aerobic expression in E. 
coli BL21(DE3) co-transformed with the pEC86 vector harboring 
ccmA-H.11 In the absence of the pEC86 plasmid, the low levels of 
Ccm proteins expressed under aerobic conditions lead to very 40 
poor heme incorporation (< 6 %), producing large amounts of 
apoprotein (Supplementary information, Fig. S2) and reflecting 
the low levels of CcmE constitutively expressed under aerobic or 
micro-aerobic conditions. To further probe the mechanism of 
heme incorporation, pSHTctmaq was co-transformed with 45 
pEC864 - a variant of pEC86 harbouring the catalytically inactive 
H130A mutant of CcmE12 - into E. coli strain EC65 (ΔccmE).13 
The absence of any catalytically active CcmE under these 
conditions results in a small quantity of b-type heme binding (but 
no c-type heme binding) to 2, highlighting the necessity of CcmE 50 
for efficient c-type heme incorporation into the maquette. Since 
heme C can be covalently incorporated into some natural c-type 
cytochromes under reducing conditions in vitro,14,15 we attempted 
to do so with apo-2 and both hemin and zinc protoporphyrin IX. 
We were unable to detect appreciable levels of covalent heme 55 
incorporation in vitro with either porphyrin, even after a week of 
incubation, further indicating the necessity of the CcmE protein 
for efficient maturation. With concomitant pEC86 expression of 
CcmA-H, the highest levels of expression and heme 
incorporation (where ~ 90 % of proteins contain heme C) occur 60 
during 15 hour aerobic expression in Luria-Bertani broth at 37 
oC, the red color of the cell paste serving as a useful indicator of 
expression levels. Following cell lysis by sonication and Ni-NTA 
affinity chromatography, the His-tag was cleaved by TEV 
protease. To remove residual apo-protein and a small quantity of 65 
proteolysed protein, the crude protein was further purified by 
reverse-phase HPLC. MALDI-TOF mass spectrometry confirmed 
covalent incorporation of heme C (calculated mass = 15758 Da; 
observed mass = 15780 Da, 2 + Na+, Supplementary information, 
Fig. S3). Treatment of 2 with acidified 2-butanone16 does not lead 70 
to heme partitioning into the organic solvent (Supplementary 
information, Fig. S4), a characteristic that differs from proteins 
containing heme B but one that is shared with covalently bound 
heme C containing proteins. The UV/vis spectrum of the ferrous 
protein 2 (Fig. 2A) exhibits the expected blue shift in the 75 
Soret/alpha/beta absorption bands compared to ferrous protein 1, 
consistent with a modification of the vinyl groups on the 
conjugated porphyrin.17,18 There is a greater degree of spectral 
shift in comparison with the single thioether-linked heme in the 
synthetic de novo cytochrome c reported by Isogai17 but a shift 80 
similar to that observed by Barker in converting cytochrome b562 
to a c-type cytochrome.18 Further confirming the nature of the 
heme species, the reduced pyridine hemochrome spectrum is 
identical to that of horse heart cytochrome c and those reported 
for natural c-type cytochromes19 (Fig. 2B), and significantly 85 
shifted with respect to b-type heme containing proteins and the 
single thioether-linked heme in the synthetic de novo cytochrome 
c of Isogai.17 Ferric and ferrous UV/visible (Fig. 2A) and EPR 
spectra (Supplementary information, Fig. S5) of 2 are indicative 
of 6-coordinate bis-histidine ligated heme C.20,21 90 
Heme C containing maquette binds O2 
Despite the modifications to the original design (1), 2 retains the 
ability to undergo ligand exchange between the histidine 
sidechain occupying the 6th coordination site on heme C and 
either CO or O2 (Fig. 3A,B). The spectral changes observed on 95 
binding CO and O2 are similar to those observed for the 
corresponding heme B-bound species of 16 and the oxyferrous 
absorbance spectrum is consistent with the oxyferrous spectra of 
the few natural and engineered c-type cytochromes that can 
undergo reversible oxygen binding (Supplementary information, 100 
Table S2).22-24 The lifetime of the oxyferrous species of 2 is 
similar to those observed for 16 and 1.5 (1, t1/2 = 9.4 seconds; 1.5, 
t1/2 = 10 seconds; Supplementary information, Table S3), though 
autoxidation at 15 oC occurs less rapidly (t1/2 = 15 seconds), 
indicating a slight stabilization of the oxyferrous species on 105 
switching between hemes B and C. This rate is significantly more 
rapid than the autoxidation rates of the natural globins25,26 and the 
natural and engineered c-type cytochromes,27,28 most likely due to 
the relatively low reduction potential of the hemes in 2 and the 
other oxygen-binding maquettes,6 but it is within the range of 110 
autoxidation rates exhibited by the oxygen binding and activating 
cytochromes P450 (Supplementary information, Table S3).29-31 
Physical chemistry of mixed Heme C/B maquettes. 
Titration of one equivalent of heme B into 2 creates a mixed 
heme C/B maquette (Fig. 4).  Analytical ultracentrifugation of the 115 
C and C/B maquette showed that both sedimented as monomeric 
4-helix bundles with the data fitting to species with molecular 
weights of 18,340 Da and 17,210 Da (Fig. 5A,B - residuals 
plotted in Supplementary information, Fig. S6), corresponding to 
1.16x and 1.05x the monomer mass respectively (15,758 and 120 
16,374 Da). Circular dichroism spectroscopy indicated both to be 
highly α-helical with an increase in helicity on heme B ligation 
(Fig. 5C). Visible CD spectra indicated that the hemes reside in 
chiral environments in both C and C/B forms. However, ligation 
of heme B in the auxilliary site confers significantly more thermal 125 
stability than does heme C to the heme-free maquette (Fig. 5D; 
second derivatives of the CD melt data are plotted in 
Supplementary information, Fig. S7). Using thermal denaturation 
to probe the protein stability (monitored at 222 nm in the circular 
dichroism spectrum), the heme C form melting transition at 34 oC 130 
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indicates the heme C does not confer significant stability 
compared to the apo-protein lacking the CXXCH motif (1.5, Tm 
42 oC, Supplementary information, Fig. S8). Given the thermal 
stability generally imparted on maquettes by the ligation of heme 
B,2 this is a surprising observation and may reflect a non-5 
idealized and strained binding geometry between heme C and the 
proximal histidine-containing helix. We were unable to determine 
the Tm of apo-2 due to the formation of oligomers in the absence 
of heme C. Binding heme B to the empty site of the heme C form 
leads to a dramatic 32 oC increase in Tm and a significantly more 10 
cooperative melting transition. More support for the stabilizing 
effect of heme B, as opposed to heme C, is found in the broad 1D 
1H NMR spectrum of 2, an indicator of conformational averaging 
of the protein scaffold and thus a protein with a mobile, liquid 
interior (Supplementary information, Fig. S9), compared to the 15 
distinct sharpening of the NMR signals on adding heme B.  
The additions of a connecting inter-helix loop and thioether 
linkages to the heme macrocycle raise the heme C redox midpoint 
in 2 by 54 mV compared to the B heme 1 (-252 to -198 mV vs 
NHE, Supplementary information, Fig. S10), possibly accounting 20 
for the increase in the lifetime of the oxyferrous state. The C and 
B heme redox potentials in the mixed C/B maquette are -188 mV 
and -250 mV respectively (Fig. 6). The greater than 60 mV split 
in the redox potentials means that electron transfer from B to C 
will be more than 10 times more favorable than the reverse 25 
reaction, providing direction to the nascent electron transfer 
chain.32  
Conversion to a photoactive maquette 
By covalently appending the cofactor to the protein backbone, 
diverse functionality can be incorporated into the heme C site of 30 
the maquette whilst maintaining a robust scaffold with the 
capacity for a secondary or complementary function at the 
auxiliary tetrapyrrole binding site. Since c-type cytochromes 
undergo facile demetallation in the presence of hydrofluoric acid 
and remetallation by zinc to produce light sensitive porphyrins, 35 
the heme C in 2 can be modified to create a maquette capable of 
simple light-activated electron/energy transfer. Using a protocol 
first devised by Vanderkooi,33 lyophilized heme C maquette is 
dissolved in 70% hydrogen fluoride in pyridine, the almost 
instantaneous color change to purple indicates the formation of 40 
the metal-free form. Following removal of the excess hydrogen 
fluoride and pyridine, reloading with zinc by stirring with an 
excess of Zn2+ at pH 2 produces Zn cytochrome c form 
(Zn(II)(2)), which retains the auxiliary tetrapyrrole binding site. 
The UV/visible spectra and fluorescence excitation and emission 45 
spectra of metal-free and Zn porphyrin forms (Fig. 7) are 
consistent with those obtained for the metal free and zinc horse 
heart cytochrome c.33 Adding 1 equivalent of heme B resulting in 
the mixed ZnC/B form (Supplementary information, Fig. S11). 
This binding of heme B to the auxiliary site quenched the 50 
fluorescence of the covalently appended zinc porphyrin by 
approximately 40 %, indicating the presence of an efficient 
energy transfer mechanism between chromophores with 
overlapping emission/absorbance spectra, a feature common to 
natural light harvesting complexes.34 55 
Discussion 
We have shown that it is plausible to practice synthetic biology 
with completely artificial redox proteins that plug in to natural 
biochemical pathways and are functionalized in vivo.  
Furthermore, with maquettes we can potentially customize inter-60 
protein interactions by adjusting the patterning of the maquette 
external charges to be complementary with localized regions of 
natural protein surface charge, independent of the incorporation 
of hemes in the interior. We have also described a tractable 
procedure whereby a designer 4-helix bundle capable of non-65 
covalently binding heme cofactors can be converted into a 
functional artificial c-type cytochrome. The design criteria are 
simple: take an existing heme B binding protein maquette and 
convert to a single chain 4-helix bundle to break the bundle 
symmetry and satisfy the required heme C ligation, in this case 6-70 
coordinate bis-histidine ligation; incorporate the consensus 
CX1X2CH motif derived from natural c-type cytochrome 
sequences and co-express in the E. coli periplasm with the natural 
cytochrome c maturation genes. Efficient translocation to the 
periplasm is achieved by appending the natural N-terminal signal 75 
sequence from MBP, demonstrating the compatibility of artificial 
protein sequences with complex cellular machinery, resulting in a 
very high percentage of the translocated protein. Efficient heme 
incorporation into the maquette is only achieved in the E. coli 
periplasm in the presence of active, co-expressed heme lyase, 80 
CcmE (Supplementary information, Fig. S2).4 
We caution that working with in vivo Ccm maturation proteins 
may require that our artificial proteins designs are not overly 
robust and thermally stable. Apo-horse heart cytochrome c is 
largely unfolded under physiological conditions,35 only attaining 85 
the native state on heme B binding or heme C incorporation.36 A 
similar situation is likely to exist for the double cysteine mutant 
of cytochrome b562 engineered for c-type heme incorporation 
(cytochrome cb562): wild type apocytochrome b562 exists in a 
molten globule-like state,37 while the mature cytochrome cb562 90 
adopts a native state almost identical to that of the b-type heme 
containing version.38,39 Such behavior is indicative of a 
preference of the maturation system for protein substrates with 
heme binding sites that exhibit disordered or at least molten 
globular characteristics when unoccupied, thus decreasing the 95 
kinetic barrier of chaperone-presented heme binding to the 
protein (via the CcmE heme lyase in the E. coli), the first step in 
covalent heme incorporation.4 Since our c-type cytochrome 
maquette exhibits a relatively low Tm, we surmise that the high 
efficiency of heme incorporation can be attributed to the 100 
dynamic, molten state of the maquette.  
The prokaryotic E. coli Ccm proteins are capable of incorporating 
heme C into a wider variety of c-type cytochromes compared to 
the eukaryotic system, which display marked specificity for 
eukaryotic cytochromes c and c1 (the only known eukaryotic c-105 
type cytochromes).4 A recent study by Kranz40 has demonstrated 
that the S. cerevisiae maturation apparatus can process 
prokaryotic homologues of eukaryotic cytochrome c, provided 
that a sequence recognition motif41 is included preceding the 
CXXCH motif at the N-terminus of the apoprotein substrate. 110 
Furthermore, the complex of holocytochrome c synthase (HCCS), 
a eukaryotic cytochrome c maturation protein responsible for 
terminal heme transfer and attachment, and apocytochrome c is 
primarily mediated by interactions with heme at the 
protein:protein interface.40 Since the heme ligands of the nascent 115 
heme C binding site are provided by a histidine from the CXXCH 
motif of the apocytochrome c substrate and a histidine from 
HCCS, it would appear that effective interfacing with HCCS and 
thus maturation with this system would require an unfolded 
apocytochrome substrate. We therefore postulate that the 120 
inclusion of the additional recognition sequence to our c-type 
maquette coupled with the partially unfolded nature of the apo-
maquette under physiological conditions may enable efficient 
heme incorporation through this maturation system, thereby 
facilitating the in vivo assembly of artificial c-type cytochromes 125 
in eukaryotic organisms. 
There is only one known example of a natural, oxygen binding c-
type cytochrome that forms the oxyferrous state in the wild-type 
protein: Sphaeroides Heme Protein (SHP), a class 1 cytochrome c 
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from Rhodobacter sphaeroides and related proteobacteria.24,28 
SHP adopts the fold of a typical cytochrome c, but with either the 
unusual His/Asp or the more common bis-His ligation scheme. 
Both ligation schemes free up the sixth heme coordination site for 
diatomic ligand binding when reduced, favoring mono-His 5 
ligation in the ferrous state.42 Two examples also exist of 
oxyferrous states in engineered variants of cytochrome c (horse 
heart cytochrome c, S. cerevisiae iso-1-cytochrome c)22,23,27 
where the distal heme-ligating methionine ligands are replaced 
with alanine, freeing the sixth coordination site for ligand 10 
binding. The oxyferrous state is exceptionally long-lived in the 
engineered iso-1-cytochrome c,27 exhibiting an autoxidation rate 
that is significantly lower than that of myoglobin.26 Taken with 
the oxygen-binding capabilities of 2, we therefore conclude that 
the covalent linkages of heme C do not interfere with or limit the 15 
oxygen binding capabilities of c-type cytochromes, and that the 
lack of characterized, natural oxygen-binding c-type cytochromes 
is not due to an intrinsic issue with the biophysical properties of 
heme C per se. We also believe our heme C maquettes have the 
capacity for further incorporation of functional elements that may 20 
support the activation of bound molecular oxygen for catalytic 
hydroxylation. Indeed our cytochrome c maquette displays an 
oxyferrous autoxidation rate that falls well within the range of the 
oxygen binding and activating cytochromes P450,29-31 thus 
potentially providing a robust scaffold for studying oxygen 25 
activation in the context of an artificial protein. 
In engineering artificial redox proteins, there is a great advantage 
to covalently securing the tetrapyrrole redox cofactor. The 
covalent modification confers on the protein an effectively 
infinite affinity for heme. Heme C redox and biophysical 30 
properties can thus be modulated by selecting alternative ligation 
schemes such as 6-coordinate His/Met and 5-coordinate mono-
His, facilitating site differentiation in a maquette over hundreds 
of millivolts scale and the formation of 5-coordinate catalytic 
heme sites for small molecule binding and subsequent redox 35 
catalysis. Such modulation of cofactor reduction potential is a key 
factor in the functional engineering of natural heme-containing 
oxidoreductases, largely dictating the enzymatic function of the 
cofactor,2 or, when incorporated into a chain of redox cofactors, 
the driving force for and direction of electron transfer.32   40 
Furthermore, the covalent incorporation of heme should enable 
dense packing of hemes within an artificial cytochrome. Natural 
b-type cytochromes rarely contain more than 2 hemes per 
polypeptide chain or discrete functional unit, while there are 
many examples of c-type cytochromes with between 4 and 34 45 
hemes per polypeptide chain.43 These multiheme c-type 
cytochromes often arrange their heme cofactors in close 
proximity to support very rapid electron transfer rates across long 
distances, functioning very much like a protein-insulated wire. 
The protein maquettes reported here might be redesigned for 50 
multi-electron reduction and oxidation of small molecules or 
expressible, self-assembling molecular wires for extracellular 
metal reduction.   
Since maquettes have a demonstrated ability to accommodate a 
wide range of cofactors in a relatively malleable interior, further 55 
development of these artificial multi-cofactor oxidoreductases 
can exploit a rich combinatorial diversity of cofactor moderated 
functions within a single protein,44 often with only minor 
modification of the protein framework, ranging from reversible 
oxygen binding (an obligate intermediate in cytochrome P450 60 
and heme dioxygenase catalysis3) to light-activated electron 
transfer. 
Materials and methods 
Molecular Biology, Expression and purification 
Synthetic genes were obtained from DNA2.0 (USA), and 65 
expressed from a modified variant of pMal-p4x (pSHT) and the 
proteins were purified using a combination of standard Nickel-
affinity chromatography and high performance liquid 
chromatography (as described in the Supplementary information). 
The preparation of metal-free and Zn-substituted 2 is described in 70 
the Supplementary information. 
Spectroscopy and biophysical characterization 
Detailed procedures for maquette characterization by UV/visible, 
fluorescence, EPR, NMR and CD spectroscopies, stopped-flow 
spectrophotometry, AUC, MALDI-TOF mass spectrometry and 75 
spectroelectrochemistry are contained within the Materials and 
Methods section of the Supplementary information. 
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Fig. 1. Design and expression of a single-chain, artificial c-type cytochrome. A, Heme B is covalently attached to the substrate protein 
backbone via thioether linkages between the peripheral vinyl substituents on the porphyrin and the cysteine sidechains within the consensus 
CXXCH motif. This is achieved in E. coli with the cytochrome c maturation proteins (CcmA-H) located in the periplasmic space. B, Starting 
with the designed oxygen transport maquette, 1, 2 loops (comprising glycine and serine) and a 4-residue N-cap (MTPE) are added to allow 
symmetry breaking across the 4-helix bundle and to add rigidity at the N-terminus. The CXXCH motif is then added into the sequence for 
covalent heme incorporation by the E. coli cytochrome c maturation apparatus (2). Changes to the amino acid sequence between iterations are 
highlighted in red, heme ligating histidine residues in blue and loops and N-termini in purple. Cartoon representations of the proteins are 
indicated to the right of the sequences: heme-ligating histidines are represented by blue pentagons, loops and N-/C-termini by purple lines, 
heme C positioning by the red rectangular box. C, The N-terminal signal sequence from the periplasmic E. coli maltose binding protein (MBP, 
black) is cleaved between A and K on transport across the inner membrane. A hexa-histidine tag (white) facilitates purification on Ni-NTA, 
and can be subsequently cleaved through the addition of a TEV protease cleavage site (blue - ENLYFQ-G). D, This expression system yields 
highly efficient heme incorporation into the expressed 2. 
 








































































Fig. 2. Spectroscopic characterization of the c-type cytochrome maquette. A, UV/visible spectra of ferrous 1 with 
bound heme B (red) and purified 2 with covalently incorporated heme C (blue) reveals the expected blue-shift in the 
absorption spectrum of the c-type heme. B, UV/visible spectra of the pyridine hemochrome (α/β region) preparations of 
horse heart myoglobin (red, MgB), bovine cytochrome c (blue, Cyt c) and 2 (black). Stereotypical peak positions for b-
type heme and c-type heme are indicated by dashed lines, highlighting the spectroscopic fingerprint for c-type heme in 
2. 
 








































































Fig. 3. Exogenous ligand binding by 2. UV/visible spectra in the A, Soret (ɣ), B, and Q-band (α/β) regions of 
ferrous (blue), ferric (green), oxyferrous (red) and carbonmonoxyferrous (black) 2. C, Oxyferrous decay 
kinetics measured at 568 nm indicating the rate of autoxidation from oxyferrous to ferric 2 + superoxide (O2-). 
Raw data are displayed in black with a single exponential fit in red.  
 








































































Fig. 4. 2 binds 1 equivalent of heme B per 4-helix bundle. A, UV/visible spectra  from the titration of 0.5 µM hemin aliquots 
(0.5 mM hemin in DMSO) into 5 µM 2 (1 cm pathlength cuvette, 25 oC, 20 mM phosphate, 100 mM KCl, pH 7.5). B, heme 
binding isotherm indicating a stoichiometry of 1 heme B per molecule of 2 (dashed line). 
 
















































Fig. 5. Structural characterization of 2. A, B. Analytical ultracentrifugation of 15 µM 2 (A) and 15 µM 2 + heme B (B) in redox buffer (20 mM 
phosphate, 100 mM KCl, pH 7.5). Data were fitted to models of 1.16x the calculated MW for 2 and 1.05x the calculated MW for 2 + heme B. 
Residuals for the fits are plotted in SI Appendix, Fig. S6. C, Far-UV circular dichroism spectra of 2 (red) and 2 + heme B (blue) at 5 µM in redox 
buffer (20 mM phosphate, 100 mM KCl, pH 7.5). Inset, Near-UV/visible CD of 2 (red) and 2 + heme B (blue). (conditions as for far-UV CD 
measurements). D, Temperature dependence of the CD signal @ 222 nm for 2 (red) and 2 + heme B (blue), highlighting the increase in thermal 
stability (ΔTm = +32 oC) on occupying the second heme binding site (conditions as for far-UV CD measurements). 
 








































































Fig. 6. Redox potentials of c-type and b-type heme in 2 + heme B. A. UV/visible spectra of the 
potentiometric titration of 2 + heme B (61 µM, 50 mM phosphate, 500 mM KCl, 10% glycerol, pH 
7.5). B. Determination of redox potentials of c- and b-type hemes in 2 + heme B. Reductive (closed 
circles) and oxidative (open circles) data are fitted with 1-electron Nernst curves and quoted vs the 
Nernst hydrogen electrode (NHE). The proportion of reduced heme (y-axis) was determined for each 
sample at wavelengths where the contribution to the absorbance change was exclusive to the type of 
heme (c-type - 418 nm; b-type - 432 nm). 
 








































































Fig. 7. Generation of a covalently-appended, light-sensitive cofactor in 2. A. UV/visible spectra of ferric 
(Fe(III)(2), red), demetallated (H2(2), pink) and zinc (II) (Zn(II)(2), blue) 2 (5 µM protein, 20 mM phosphate, 
100 mM KCl, pH 7.5). Iron is removed from the porphyrin with HF:pyridine solution, then after purification 
of demetallated 2 (H2(2)), Zn2+ can be inserted to create a covalently bound, photosensitive cofactor. B. 
Fluorescence excitation (green) and emission (magenta) spectra of Zn(II)(2) (900 nM, 20 mM CHES, 150 
mM KCl. pH 9.0). Emission spectra were recorded with an excitation wavelength of 420 nm in both heme-
free and heme-bound Zn(II)(2) and normalized to the Zn(II)(2) maximum at 586 nm.  
 





SUPPLEMENTARY INFORMATION 5 
 
Supplementary Methods and Materials 
 
Chemicals. Hemin was purchased from Frontier Scientific. All other chemicals were purchased from 
Sigma or Fisher Scientific.  10 
 
Molecular biology. All cloning and mutagenesis was performed using the ligase-independent 
cloning/mutagenesis method of Tillett (1). The heme B-binding precursor of 2.0 (1.5) synthetic genes 
was obtained from DNA2.0 (USA). 1.5 was subcloned into pMal-p4x (NEB, USA) including the E. 
coli periplasmic maltose binding protein (MBP) as a fusion tag. 1.5 in pMal-p4x was mutated to insert 15 
the consensus CIACH motif required for c-type heme incorporation and the vector was altered to 
remove the MBP sequence, with the exception of the 26 amino acid periplasmic signal sequence. A 
cleavable N-terminal hexahistidine tag with a C-terminal tobacco etch virus N1a (TEV) protease-
cleavable sequence were added after the periplasmic signal sequence to facilitate purification, 
producing the vector pSHT2.  20 
 
Expression and purification.  All proteins were expressed in BL21(DE3) cells. 2 was co-expressed 
with the E. coli cytochrome c maturation genes (ccmA-H) encoded on the pEC86 plasmid (2). All 
proteins were expressed and purified using the same protocol: transformed bacteria were grown in 
Luria-Bertani broth at 37 oC until the OD600 of the media reached 0.6—0.8. Protein expression was 25 
induced by the addition of IPTG (0.5 mM). We found that expressing 2 overnight (~15 hrs) before 
centrifugation yielded the best c-type heme incorporation. Cells were resuspended in 40 ml lysis buffer 
(50 mM phosphate, 100 mM KCl, 10 mM Imidazole, pH 8) per liter of culture, and sonicated on ice 
for 5 x 10 s pulses, with 10 s pauses. 1 ml of 100 mM PMSF per ml of lysis buffer was added before 
and after sonication to inhibit any protease activity in the lysate. Lysed cells were centrifuged at 30 
20,000 g for 45 min and the resulting supernatant was loaded on to a Nickel-Sepharose His-Trap 
column (GE, USA) that had previously been equilibrated with lysis buffer, using an AKTA FPLC 
system (GE, USA). The column was washed with lysis buffer until the absorbance at 280 nm of the 
flow-through became stable. The bound protein was eluted using a linear gradient of imidazole, and 
the resulting fractions that contained protein of the correct molecular weight (as determined by gel 35 
electrophoresis) were pooled and dialyzed in to TEV cleavage buffer (50 mM Tris-HCl, 0.5 mM 
EDTA, 1 mM DTT, pH 8.0) and cleaved over night using TEV protease. Prior to HPLC purification, 
heme C is incorporated into 85 - 95 % of the c-type cytochrome maquette 2. The final purification step 
was high performance liquid chromatography (HPLC) performed on a Jasco PU980 HPLC system in 
conjunction with a reverse-phase C18 column. Proteins were eluted using a linear gradient of 40 
acetonitrile (Fisher) in water and 0.1 % trifluoroacetic acid (Sigma Aldrich). The identity of the 
purified proteins were confirmed by matrix assisted laser desorption ionization time of flight (MALDI-
TOF) mass spectrometry, performed on a 4700 TofTof mass spectrometer (Applied Biosystems). 
 
Electronic spectroscopy and stopped flow spectrophotometry. UV/visible spectra were recorded on 45 
an Agilent Cary 60 spectrometer (Agilent, USA). Heme binding stoichiometries were determined by 
titrating solutions of hemin (0.1 - 2 mM in DMSO) into 2 at varying concentrations of protein (1 - 10 
µM) and plotting ΔAbs vs [hemin] added. Pyridine hemochrome spectra of 2, myoglobin and horse 
heart cytochrome c were recorded using the method of Berry and Trumpower (3). Extinction 
coefficients for 2 were calculated using the results of the pyridine hemochrome and were ε280 nm = 50 
 14  |  Journal Name, [year], [vol], 00–00 This journal is © The Royal Society of Chemistry [year] 
25780 M-1cm-1 and ε408 nm = 121400 M-1cm-1 for ferric 2 and ε418 nm = 172700 M-1cm-1 for ferrous 2. 
Stopped-flow UV/vis spectra of oxyferrous and carbonmonoxy 2 were collected either with an OLIS 
RSM 1000 spectrometer (OLIS, USA) or an Applied Photophysics SX20 spectrometer (Applied 
Photophysics, UK) housed in a Belle Technology anaerobic glove box (Belle Technology, UK). 
Solutions of ferrous 2 in redox buffer (20 mM phosphate, 100 mM KCl, pH 7.5) were prepared by 5 
carefully titrating sodium dithionite into degassed, anaerobic ferric 2 solutions and either transferred 
directly into the loading syringe of the anaerobically-housed SX20 spectrometer or via cannula into 
that of the RSM 1000 spectrometer. Full near-UV/visible spectra (300 - 800 nm) were recorded and 
the data analyzed using IgorPro (Wavemetrics, USA). Fluorescence excitation and emission spectra 
were recorded on a Fluorolog 3 fluorimeter (Horiba, Japan) with entrance and exit slits of 2 nm width. 10 
Emission spectra were recorded with an excitation wavelength of 420 nm in both heme-free and heme-
bound Zn(II)(2). Electron paramagnetic resonance spectra were recorded using a Bruker Elexsys E500 
spectrometer at X-band (9.4 GHz) using an Oxford Instrument ESR900 helium flow cryostat. 
 
Heme extraction. The heme extraction test was performed according to the method of Teale (4). 2 ml 15 
of heme protein (50 µM) was added to ice-cold, acidified 2-butanone (50 µl concentrated HCl in 2 ml 
2-butanone chilled in an ice/salt bath). The mixture was briefly shaken and then allowed to phase 
separate. Non-covalently bound heme B is extracted into the upper organic layer and covalently 
incorporated heme remains bound to the protein in the aqueous layer. 
 20 
Circular dichroism. CD spectra were obtained using a JASCO J-810 spectropolarimeter fitted with a 
Peltier temperature controller (Jasco, UK). Thermal melts were performed with heating rates of 60 
oC/hour with data points taken at 222 nm (bandwidth 3 nm, 16 s integration time) every 1 oC, and full 
spectra recorded every 20 oC (100 nm/min, bandwidth 1 nm).  
 25 
Analytical ultracentrifugation. Analytical ultracentrifugation of 2 was performed using a Beckman-
Optima XL-I analytical ultracentrifuge fitted with an An-60 Ti rotor. Peptide solutions (15 µM) were 
prepared in a buffer solution comprising 20 mM potassium phosphate and 100 mM potassium chloride 
at pH 7.5. Sedimentation equilibrium data were fitted simultaneously with Ultrascan (5) using a single 
ideal species model; protein partial specific volumes (0.7192 and 0.7186 without and with the b-type 30 
heme bound, respectively) were estimated using Sednterp (http://www.jphilo.mailway.com/), taking 
the partial specific volume of heme to be 0.881 ccm/g (6). The calculated molecular weight of 2 was 
18300 Da (1.16x monomer mass), and that of 2 + heme B was 17210 Da (1.05x monomer weight). 
 
Nuclear magnetic resonance. Solutions of 0.5 mM 2 and 2 + heme B were prepared in redox buffer 35 
containing 10% v/v D2O (Sigma Aldrich, UK). 1D spectra were acquired using a Shigemi tube (Sigma 
Aldrich, UK) on a Varian INOVA 600 (University of Bristol) using double-pulsed field gradient spin-
echo excitation for water suppression. Spectra were processed using NMRPipe (7) and visualized 
using the CCPNMR software suite (8). 
 40 
Redox potentiometry. Anaerobic potentiometric titrations were performed using a modified quartz 
EPR OTTLE cell—equipped with platinum working and counter electrodes and a Ag/AgCl reference 
electrode (BASi, USA)—in concert with a Biologic SP-150 potentiostat (Bio-logic, France) and Cary 
60 UV/visible spectrometer (Agilent, USA). Titrations were performed in OTTLE buffer (50 mM 
phosphate, 500 mM KCl, 10 % glycerol, pH 7.5) using a protein concentration of between 50 - 150 45 
µM, and included the following redox mediators at 20 µM concentration: phenazine, anthroquinone-2-
sulfonate, 2-hydroxy-1,4-naphthoquinone, benzyl viologen. Heme reduction potentials were 
determined by fitting the data to the Nernst equation (Equation 1) using IgorPro software 
 This journal is © The Royal Society of Chemistry [year] Journal Name, [year], [vol], 00–00  |  15 
(Wavemetrics, USA). Reported reduction potentials are quoted vs the Nernst hydrogen electrode 
(NHE). 
 
Eqn. 1. Eapplied = Em + RT/nF.In([Ox]/[Red]) 
 5 
Preparation of metal-free, zinc and zinc/heme B maquette 2. 3 mg of 2 was thoroughly lyophilized 
to ensure no water was present in the sample. 1.5 ml of 70% hydrogen fluoride in pyridine was added 
and the solution stirred for 10 minutes in the dark. The HF was evaporated under an argon stream and 
the metal-free 2 (H2(2)) was dissolved in 2 ml of 50 mM ammonium acetate, pH 2.0. Residual pyridine 
was removed using a PD-10 desalting column (GE, USA), and 5 equivalents of zinc acetate were 10 
added to H2(2) while the pH was maintained at pH 2.0. Zinc incorporation was monitored by 
UV/visible spectroscopy. After incorporation was complete, the protein was lyophilized and 
redissolved in 20 mM CHES, 150 mM KCl, pH 9.0 for characterization and heme B incorporation. 
Titrations were performed on 1 ml of 900 nM Zn(II)(2) calculated using the extinction coefficient of 
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3M4CA 2YYWA 3OA8A 2B7SA 1SP3A 1FGJA 2J7AA 3M15A 
1S05A 2YYXA 2C1DA 1M64A 1SP3A 1FGJA 2J7AC 1M1QA 
1CGOA 2J8WA 2C1DA 2E84A 1SP3A 1QO8A 1KSUA 3BNJA 
1CGNA 2ZZS1 1CZJA 2E84A 1GU2A 1Q9IA 1KSSA 1W7OA 
2RDZA 1GYOA 1EYSC 2E84A 2XLWA 2DVHA 2BQ4A 2VR0A 
2OT4A 2XM4A 1EYSC 2E84A 2XLEA 1GQAA 2BQ4A 1VRNC 
1J0PA 1OFWA 3PMQA 2E84A 2XL8A 2CCYA 1FT5A 1MDVA 
1J0OA 1OFWA 1AQEA 2E84A 2XL6A 1MQVA 1FT5A 1H32A 
1H29A 1WADA 3L1MA 1P2HA 2XLMA 1A7VA 1LJ1A 1H32A 
1H29A 2WJNC 2CTHA 1P2EA 1DUWA 1DT1A 2CDVA 3H34A 
1H29A 2WJNC 2CY3A 2BC5A 1DUWA 1Y0PA 3HNKA  
1H29A 1BBHA 3CYRA 2YXCA 3FOOA 1Z1NX 3HNJA  
1H29A 1CPQA 1D4DA 3H4NA 3FO3A 1Z1NX 1JRXA  
1H29A 1CPRA 1D4CA 2A3MA 1QDBA 1Z1NX 1JRYA  
1H21A 1I77A 3QW0A 2CVCA 2EWKA 1Z1NX 1JRZA  
2P0BA 3ML1B 1WR5A 2CVCA 2EWIA 1Z1NX 19HCA  
2JBLC 1E39A 1C52A 2CVCA 2EWUA 1Z1NX 19HCA  
2JBLC 3DE8A 3C62A 2CVCA 2Z47A 1Z1NX 1FS7A  
3IQ5A 3CAOA 3C63A 2CVCA 3NMIA 3RKHA 1FS9A  
2RF7A 1OAHA 2B7RA 2CVCA 1FGJA 1UP9A 3SCEA  
 
 5 
Table S1. PDB codes of c-type cytochromes with heme C binding sites located on a helix. Multiple 














 Oxyferrous lmax (nm)  
  c-type cytochromes   g b a Ref 
2 410 535 571 This work 
Iso-1-cytochrome c M80A 408 537 570 30 
Semi-synthetic horse heart cytochrome c M80A n/a 535 571 31 
SHP (Sphaeroides heme protein) 408 538 570 32 
 
 
Table S2. UV/visible absorbance data for c-type cytochrome oxyferrous species, comparing the 



































Heme protein kauto (h-1) t1/2 (s) Temp (oC) Ligation Heme  Ref 
2 165 15 15 His/His* c-type This work 
1.5 240 10 15 His/His* b-type This work 
1 266 9.4 15 His/His* b-type This work 
Murine neuroglobin 19 130 37 His/His* b-type 33 
Human neuroglobin 5.4 460 37 His/His* b-type 33 
Sperm whale myoglobin 0.083 3 x 104 35 His b-type 34 
P450cam - camphor 51 50 25 Cys b-type 37 
P450 3A4 + testosterone 1300 1.9 4 Cys b-type 38 
P450 BM3 + arachidonic acid 792 3.15 20 Cys b-type 39 
Iso-1 cytochrome c M80A 0.01 2 x 105 22 His c-type 35 




Table S3. Comparison of oxyferrous state autoxidation rates (kauto) and half lives (t1/2) of the maquette, 
2, with natural oxygen binding proteins. Though less stable to autoxidation with respect to the globins, 
2 exhibits autoxidation kinetics in the range of the oxygen binding and activating cytochromes P450. 10 
Ligation refers to the iron-coordinating ligands in the ferrous heme state. * - The neuroglobins and 
oxygen binding maquettes undergo rapid ligand exchange at the distal histidine site, and the heme 








































Fig. S1. Weblogo of 150 helical c-type heme CX1X2CH motifs extracted from the Protein Data Bank 
(PDB, http://www.rcsb.org/pdb/home/home.do). PDB files of natural cytochromes were downloaded 
from the non-redundant structural database (from the PISCES server) where the following conditions 
were satisfied: any CXXCH motif found on a helix of a non-redundant structure containing HEM or 
HEC. PDB files were hand-curated, the c-type binding motif recorded then visualized using WebLogo. 15 



































Fig. S2. Covalent heme incorporation is dependent on the presence of the heme lyase CcmE. A, The 
harvested pellet of E. coli expressing 2 in the absence (left) and presence (right) of the ccmA-H 
containing pEC86 vector indicates a significant increase in heme concentration in vivo when the vector 10 
is present. B, UV/visible spectroscopic comparison of Ni-sepharose purified 2 expressed in the 
absence (blue) and presence (red) of the pEC86 vector harboring the fully functional c-type 
cytochrome maturation apparatus. When co-expressed in E. coli strain EC65 (ΔccmE) with pEC864 – 
a variant of pEC86 with catalytically inactive CcmE (H130A CcmE) – no c-type heme is observed and 
the protein instead is purified with b-type heme bound (magenta). All traces are normalized to the 15 
protein absorbance at 280 nm, and ratios of the absorbances at 408:280 nm (for c-type heme) or 
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Fig. S3. MALDI-TOF mass spectrum of 2 (MW = 15758 Da) collected on a 4700 TofTof mass 
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Fig. S4. The c-type heme-containing cytochrome c (Cyt c) and 2 retain heme and remain in the 10 
aqueous buffer-containing layer following treatment with acidified 2-butanone (2 ml of protein at 50 
µM, 20 mM phosphate, 100 mM KCl, pH 7.5 added to 2 ml acidified 2-butanone at -10 oC, stirred for 
5 minutes then allowed to partition) indicating covalent attachment of the heme to the protein 
backbone, while the b-type heme-containing myoglobin (MgB) and 1.5 experience heme loss to the 



































Fig. S5. EPR spectrum of ferric 2 (50 µM protein in 20 mM phosphate, 100 mM KCl), recorded at 10 
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Fig. S6. Residuals calculated from the fitted Analytical Ultracentrifugation data. Upper panel - 2; 
















Fig. S7. Second derivatives of the CD melt data for 2 (red) and 2 + heme B (blue) indicating melting 10 





























Fig. S8. Temperature dependence of the CD signal @ 222 nm for apo-1.5 (upper panel) – the single 
chain maquette lacking the CXXCH motif - and the second derivative of the temperature dependence 
data (lower panel, Apo-1.5, Tm = 42 oC). The amino acid sequence of 1.5 is displayed in the upper 













Fig. S9. Heme B-mediated structuring of 2. 1H NMR spectra of 2 (upper panel) and 2 + heme B (lower 
panel). Spectra recorded on a Varian INOVA 600 MHz spectrometer at 500 µM 2 in redox buffer 10 
















Fig. S10. Redox potential of heme C in 2. A. UV/visible spectra of potentiometric titrations of 2 (130 
µM, 50 mM phosphate, 500 mM KCl, 10% glycerol, pH 7.5) B. Determination of redox potential of c-
type heme in 2. Reductive (closed circles) and oxidative (open circles) data are fitted with 1-electron 
Nernst curves and quoted vs the Nernst hydrogen electrode (NHE). The proportion of reduced heme 10 
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Fig. S11. Formation of a light sensitive porphyrin dyad in 2. UV/visible spectra of Zn(II)(2) and 
Zn(II)(2) + 1 equivalent of heme B (900 nM 2, 20 mM CHES, 150 mM KCl, pH 9.0). A difference 
spectrum is displayed, indicating the successful incorporation of a bis-histidine ligated heme B in the 5 
available tetrapyrrole binding site. 
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